Ovidac / HCG / Choriomon (Chorionic Gonadotropin) 5000 IU

Check our more HCG for sale:
1) HCG 15000IU (3 vials of 5000IU each) Maxtreme – 60$

Human chorionic gonadotropin brand Choriomon hCG is used primarily in fertility medicine for female and male patients. In females it is an ovary stimulant very effective in activating egg release and optimizing ovulation. With males it is used as daily injections to speed up the lowering of the eggs into the scrotum in prepuberty children and in adult males, to increase the sperm count, again as a part of fertility treatment.
The Choriomon hCG diet was first introduced by dr. Simeons in the 1950’s, unprecedented weight loss that was achieved in almost all subjects was only used in Italy. The so called dr. Simeons hcg protocol was again used in the 1970’s by a limited number in the USA, but it’s recent use and wide media attention has anabolics william llewellyn put Pregnly hcg at the top spot in obesity treatment as it has proven to boost metabolism without exercise, making long term fat loss a possibility for the first time. Because dr. Simeons hcg protocol is targeting long term fat deposits and achieving decrease in overall bodyfat as well as fat redistribution it shows promise in the ongoing battle against obesity epidemic in the developed world.
Brand namesof hcg you can purchase include: Ovidrel, Chorigon, Choron, Choriomon, APL, Gonic, Novarel, Chorex, Pregnyl, Profasi, Corion, Fertigyn, Eurtrig, Lupi, Silfasi, Proficient and many others. They all contain human chorionic gonadotropin that is available for sale in different strengths: 500, 1000, 1500, 2500, 5000 or 10 000 international units ( i.u. or u.i. for short) and are only available in the form of injectable solution. HCG drops, pellets pills or «homeopatic» preparations do not contain the active ingredient human chorionic gonadotropin and therefore do not work.

Human Chorionic Gonadotropin is an injectable drug available commercially in the United States as well as many other countries. Pregnyl, made by Organon, and Profasi, made by Serono. Among athletes, HCG is used to stimulate natural testosterone production during or after a steroid cycle which has caused natural levels to be reduced, often stacked with clomid for even better results.

Human Chorionic Gonadotropin is an injectable drug available commercially in the United States as well as many other countries. Pregnyl, made by Organon, and Profasi, made by Serono. Among athletes, HCG is used to stimulate natural testosterone production during or after a steroid cycle which has caused natural levels to be reduced, often stacked with clomid for even better results.

Stopping a steroid cycle abruptly, especially when endogenous androgens are absent, can cause a rapid loss in the athlete’s newly acquired muscle. When HCG is used to stimulate natural production, a notably pronounced crash may be avoided. This product is also not picked up on steroid tests, so some athletes use it to keep androgen levels high before a contest that has drug testing. HCG must be refergerated after it is mixed together, and it then has a life of about 10 weeks. It is taken intramuscularly only; this drug is often available by order of a physician if you show symptoms of hypogonadism.
Stopping a steroid cycle abruptly, especially when endogenous androgens are absent, can cause a rapid loss in the athlete’s newly acquired muscle. When HCG is used to stimulate natural production, a notably pronounced crash may be avoided. This product is also not picked up on steroid tests, so some athletes use it to keep androgen levels high before a contest that has drug testing. HCG must be refergerated after it is mixed together, and it then has a life of about 10 weeks. It is taken intramuscularly only; this drug is often available by order of a physician if you show symptoms of hypogonadism.

Participants and methods
Couples with unexplained infertility attending the infertility out-patient clinic in the Obstetrics and Gynecology Department Cairo University – Kasr Al-Aini Hospital were recruited for this study. The trial was conducted between January 2008 and July 2009. The local ethical committee has approved the trial and all participants gave written informed consent.
Women were included if they were less than or equal to 37years old, with a body mass index (BMI) between 20 and 30kg/m2 and with unexplained infertility. Unexplained infertility was defined based on the following criteria: normal semen analysis defined as a count more than 20?106sperm/ml, motility >50% (grade a or b, within 60min of ejaculation), morphology >50% normal forms. Bilateral patent tubes were based on hysterosalpingography and/or laparoscopy. Normal ovulation as evidenced by regular menstrual cycles and midluteal serum progesterone levels >10ng/ml.
Patients having bilateral tubal block as seen in hysterosalpingography or previously done diagnostic laparoscopy report were excluded. We also excluded women with endocrinological disorders in the form of thyroid hypo/hyper-function, hyperprolactinemia and Cushing syndrome as detected by history, examination and investigations.